fashion -WSS

fashion

author：explore 2025-10-03 00:37:50 - browse：28837

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Roche's accidental data boosts hopes for anti

WSS

Can gargling with Listerine treat gonorrhea of the mouth?

Deliver public health messages at the right time

Brain technologies pose threats that are all too real, experts warn

Lawmakers grill UnitedHealth CEO on Change cyberattack

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Crowdfunding for medical bills sidesteps core problem, author says

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

In Memoriam: Notable people who died in 2023

FDA advisory panel to debate high blood pressure devices

Hepatitis C has a cure — but many Americans still lack access to it

Wegovy improves function in certain heart failure patients

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA greenlights medical device to combat bladder issues

The cancer drug shortage isn’t new — and neither are the solutions

FDA advisory panel to debate high blood pressure devices

Heart attack and stroke risk calculators need revising

Has Bernie Sanders reached the limit of his pharma bullying effort?

entertainment

Abortion policy in the spotlight at Republican debate

HHS's proposed rule does nothing to address the climate crisis

Brain technologies pose threats that are all too real, experts warn

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Chemotherapy before breast cancer surgery might fuel metastasis

Intellia plays down concerns on accidental germline transmission

Wikipedia

knowledge

focus

explore